Sernova Biotherapeutics Statistics

Total Valuation

TSX:SVA has a market cap or net worth of CAD 55.84 million. The enterprise value is 55.18 million.

Market Cap	55.84M
Enterprise Value	55.18M

Important Dates

The next estimated earnings date is Wednesday, June 11, 2025.

Earnings Date	Jun 11, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:SVA has 328.48 million shares outstanding. The number of shares has increased by 3.18% in one year.

Current Share Class	328.48M
Shares Outstanding	328.48M
Shares Change (YoY)	+3.18%
Shares Change (QoQ)	+3.15%
Owned by Insiders (%)	4.10%
Owned by Institutions (%)	n/a
Float	315.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-3.11
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.96
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.10

Current Ratio	0.10
Quick Ratio	0.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-32.58

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-152.63%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	151.17%
Revenue Per Employee	n/a
Profits Per Employee	-1.66M
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.05% in the last 52 weeks. The beta is 1.13, so TSX:SVA's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	-54.05%
50-Day Moving Average	0.19
200-Day Moving Average	0.22
Relative Strength Index (RSI)	37.47
Average Volume (20 Days)	201,233

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-26.44M
Pretax Income	-28.13M
Net Income	-28.14M
EBITDA	-26.08M
EBIT	-26.44M
Earnings Per Share (EPS)	-0.09

Full Income Statement

Balance Sheet

The company has 1.21 million in cash and 546,468 in debt, giving a net cash position of 661,096 or 0.00 per share.

Cash & Cash Equivalents	1.21M
Total Debt	546,468
Net Cash	661,096
Net Cash Per Share	0.00
Equity (Book Value)	-17.93M
Book Value Per Share	-0.05
Working Capital	-18.50M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-19.47M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:SVA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.18%
Shareholder Yield	n/a
Earnings Yield	-50.40%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a